| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 514,630 | 514,068 | 449,570 | 494,709 | | Cost of Revenue | 425,566 | 422,242 | 370,304 | 410,143 | | | Gross Profit | 89,064 | 91,826 | 79,266 | 84,566 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,627 | 46,953 | 38,908 | 43,196 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 46,437 | 44,873 | 40,358 | 41,370 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 196 | 158 | 66 | 223 | | Earnings Before Interest And Taxes | 46,633 | 45,031 | 40,424 | 41,593 | | Interest Expense | 214 | 404 | 303 | 405 | | Income Before Tax | 46,419 | 44,627 | 40,121 | 41,188 | | Income Tax Expense | 17,181 | 16,095 | 15,643 | 16,589 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 29,238 | 28,532 | 24,478 | 24,599 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,238 | 28,532 | 24,478 | 24,599 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,238 | $28,532 | $24,478 | $24,599 |
|
0.31% Nasdaq 
0.05%
Income Statement
